References
- Achat-Mendes, C., Grundt, P., Cao, J., Platt, D. M., Newman, A. H., & Spealman, R. D. (2010). Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: Studies with preferential antagonists in squirrel monkeys. [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural]. Journal of Pharmacology and Experimental Therapeutics, 334(2), 556–565. doi:10.1124/jpet.110.167619. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20494958
- Baarendse, P. J., Winstanley, C. A., & Vanderschuren, L. J. (2013). Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task. Psychopharmacology, 225(3), 719–731. doi:10.1007/s00213-012-2857-z. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22968659
- Barrus, M. M., & Winstanley, C. A. (2016). Dopamine D3 receptors modulate the ability of win-paired cues to increase risky choice in a rat gambling task. Journal of Neuroscience, 36(3), 785–794. doi:10.1523/JNEUROSCI.2225-15.2016. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26791209
- Barrus, M. M., Hosking, J. G., Zeeb, F. D., Tremblay, M., & Winstanley, C. A. (2015). Disadvantageous decision-making on a rodent gambling task is associated with increased motor impulsivity in a population of male rats. J Psychiatry Neurosci, 40(2), 108–117. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25703645
- Barrus, M. M., Cherkasova, M., & Winstanley, C. A. (2016). Skewed by cues? The motivational role of audiovisual stimuli in modelling substance use and gambling disorders. Curr Top Behav Neurosci, 27, 507–529. doi:10.1007/7854_2015_393. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26531068
- Bechara, A. (2004). Disturbances of emotion regulation after focal brain lesions. Int Rev Neurobiol, 62, 159–193. doi:10.1016/S0074-7742(04)62006-X. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15530572
- Bechara, A., & Damasio, H. (2002). Decision-making and addiction (part I): Impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia, 40(10), 1675–1689. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1199265610.1016/S0028-3932(02)00015-5
- Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994). Insensitivity to future consequences following damage to human prefrontal cortex. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Cognition, 50(1-3), 7–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/803937510.1016/0010-0277(94)90018-3
- Boileau, I., Guttman, M., Rusjan, P., Adams J. R., Houle, S., Tong J., . . . O. Hornykiewicz (2009). Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson’s disease. [Comparative Study Research Support, Non-U.S. Gov’t]. Brain, 132(5), 1366–1375. doi:10.1093/brain/awn337. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19153147
- Boileau, I., Payer, D., Houle, S., Behzadi, A., Rusjan, P. M., Tong, J., & Wilkins, D. (2012). Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: A positron emission tomography study. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Journal of Neuroscience, 32(4), 1353–1359. doi:10.1523/JNEUROSCI.4371-11.2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22279219
- Bourdélat-Parks, B. N., Anderson, G. M., Donaldson, Z. R., Weiss, J. M., Bonsall, R. W., Emery, M. S., & Liles, Cameron L. (2005). Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. [Research Support, Non-U.S. Gov’t]. Psychopharmacology, 183(1), 72–80. doi:10.1007/s00213-005-0139-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16163519
- Buelow, M. T., & Suhr, J. A. (2009). Construct validity of the iowa gambling task. Neuropsychology Review, 19(1), 102–114. doi:10.1007/s11065-009-9083-4. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19194801
- Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., & Perry, K. W. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology, 27(5), 699–711. doi:10.1016/S0893-133X(02)00346-9. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12431845
- Cavedini, P., Riboldi, G., Keller, R., D’Annucci, A., & Bellodi, L. (2002). Frontal lobe dysfunction in pathological gambling patients. Biological Psychiatry, 51(4), 334–341. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1195878510.1016/S0006-3223(01)01227-6
- Cocker, P. J., & Winstanley, C. A. (2015). Irrational beliefs, biases and gambling: Exploring the role of animal models in elucidating vulnerabilities for the development of pathological gambling. Behavioural Brain Research, 279, 259–273. doi:10.1016/j.bbr.2014.10.043. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25446745
- Colombo, G., Maccioni, P., Vargiolu, D., Loi, B., Lobina, C., Zaru, A., & Carai, Mauro A. M. (2014). The dopamine beta-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats. Alcoholism: Clinical and Experimental Research, 38(9), 2345–2353. doi:10.1111/acer.12520. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25257286
- Cools, R., Nakamura, K., & Daw, N. D. (2011). Serotonin and dopamine: Unifying affective, activational and decision functions. Neuropsychopharmacology, 36(1), 98–113. doi:10.1038/npp.2010.121. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20736991
- Di Chiara, G. (1999). Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology, 375(1-3), 13–30.10.1016/S0014-2999(99)00372-6
- Di Ciano, P., & Le Foll, B. (2016). Evaluating the impact of naltrexone on the rat gambling task to test its predictive validity for gambling disorder. PLOS ONE, 11(5), e0155604. doi:10.1371/journal.pone.0155604. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27191857
- Di Ciano, P., Grandy, D. K., & Le Foll, B. (2014). Dopamine D4 receptors in psychostimulant addiction. Adv Pharmacol, 69, 301–321. doi:10.1016/B978-0-12-420118-7.00008-1. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24484981
- Di Ciano, P., Pushparaj, A., Kim, A., Hatch, J., Masood, T., Ramzi, A., & Khaled, Maram A. T. M. (2015). The impact of selective dopamine D2, D3 and D4 Ligands on the rat gambling task. PLOS ONE, 10(9), e0136267. doi:10.1371/journal.pone.0136267. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26352802
- Di Ciano, P., Manvich D. F., Pushparaj A., Gappasov A., Hess E. J., Weinshenker D., & le Foll B. (2018). Effects of disulfiram on choice behavior in a rodent gambling task: Association with catecholamine levels. Psychopharmacology, 235(1), 23–35.
- Di Ciano, P., McCormick P., Stefan C., Wong E., Kim A., Remington G., & le Foll B. (2017). The effects of buspirone on occupancy of dopamine receptors and the rat gambling task. Psychopharmacology, 234(22), 3309–3320
- van Enkhuizen, J., Geyer, M. A., & Young, J. W. (2013). Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: Relevance to mania. Psychopharmacology, 225(3), 661–674. doi:10.1007/s00213-012-2854-2. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22945515
- van Enkhuizen, J., Henry, B. L., Minassian, A., Perry, W., Milienne-Petiot, M., Higa, K. K., & Geyer, Mark A. (2014). Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology, 39(13), 3112–3122. doi:10.1038/npp.2014.170. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25005251
- Epstein, D. H., & Preston, K. L. (2003). The reinstatement model and relapse prevention: A clinical perspective. Psychopharmacology, 168(1-2), 31–41. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1272177810.1007/s00213-003-1470-6
- Fehr, C., Yakushev, I., Hohmann, N., Buchholz, H. G., Landvogt, C., Deckers, H., … Eberhardt, Alexandra. (2008). Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. American Journal of Psychiatry, 165(4), 507–514. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1831642010.1176/appi.ajp.2007.07020352
- Ferland, J. N., & Winstanley, C. A. (2016). Risk-preferring rats make worse decisions and show increased incubation of craving after cocaine self-administration. Addict Bioldoi, doi:10.1111/adb.12388. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27002211
- Forget, B., Wertheim, C., Mascia, P., Pushparaj, A., Goldberg, S. R., & Le Foll, B. (2010). Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology, 35(8), 1751–1760. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2035776010.1038/npp.2010.42
- Gansler, D. A., Jerram, M. W., Vannorsdall, T. D., & Schretlen, D. J. (2011). Does the Iowa gambling task measure executive function? Archives of Clinical Neuropsychology, 26(8), 706–717. doi:10.1093/arclin/acr082. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22015855
- Gaval-Cruz, M., & Weinshenker, D. (2009). mechanisms of disulfiram-induced cocaine abstinence: Antabuse and cocaine relapse. [Research Support, N.I.H., Extramural Review]. Molecular Interventions, 9(4), 175–187. doi:10.1124/mi.9.4.6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19720750
- Gendle, M. H., & Golding, A. C. (2010). Oral administration of 5-hydroxytryptophan (5-HTP) impairs decision making under ambiguity but not under risk: Evidence from the Iowa Gambling Task. Human Psychopharmacology: Clinical and Experimental, 25(6), 491–499. doi:10.1002/hup.1139. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20737522
- Goldstein, M., & Nakajima, K. (1967). The effect of disulfiram on catecholamine levels in the brain. J Pharmacol Exp Ther, 157(1), 96–102. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6029496
- Grant, J. E., Won Kim, S. W., & Potenza, M. N. (2003). Advances in the pharmacological treatment of pathological gambling. [Review]. Journal of Gambling Studies, 19(1), 85–109. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1263554110.1023/A:1021227214142
- Grant, J. E., Potenza, M. N., Hollander, E., Cunningham-Williams, R., Nurminen, T., Smits, G., & Kallio, A. (2006). Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. American Journal of Psychiatry, 163(2), 303–312. doi:10.1176/appi.ajp.163.2.303. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16449486
- Grant, J. E., Kim, S. W., & Hartman, B. K. (2008). A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. [Randomized Controlled Trial Research Support, N.I.H., Extramural]. The Journal of Clinical Psychiatry, 69(5), 783–789. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1838424610.4088/JCP.v69n0511
- Grant, J. E., Kim, S. W., Hollander, E., & Potenza, M. N. (2008). Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology, 200(4), 521–527. doi:10.1007/s00213-008-1235-3. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18581096
- Grant, J. E., Odlaug, B. L., Potenza, M. N., Hollander, E., & Kim, S. W. (2010). Nalmefene in the treatment of pathological gambling: Multicentre, double-blind, placebo-controlled study. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. British Journal of Psychiatry, 197(04), 330–331. doi:10.1192/bjp.bp.110.078105. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20884959
- Grant, J. E., Odlaug, B. L., & Schreiber, L. R. (2014). Pharmacological treatments in pathological gambling. British Journal of Clinical Pharmacology, 77(2), 375–381. doi:10.1111/j.1365-2125.2012.04457.x. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22979951
- Greenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2009). The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Pharmacology Biochemistry and Behavior, 91(3), 295–302. doi:10.1016/j.pbb.2008.07.012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18703080
- Gueye, A. B., Trigo, J. M., Vemuri, K. V., Makriyannis, A., & Le Foll, B. (2016). Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling. Behavioural Pharmacology, 27(2-3 Spec Issue), pp. 258–269. doi:10.1097/FBP.0000000000000222. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26905189
- Heidbreder, C. (2005). Novel pharmacotherapeutic targets for the management of drug addiction. European Journal of Pharmacology, 526(1-3), 101–112. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1625323410.1016/j.ejphar.2005.09.038
- Heidbreder, C. A., Gardner, E. L., Xi, Z. X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R. Jr. (2005). The role of central dopamine D(3) receptors in drug addiction: A review of pharmacological evidence. Brain Research Reviews, 49(1), 77–105. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1596098810.1016/j.brainresrev.2004.12.033
- Hloch, K., Mladenka, P., Dosedel, M., Adriani, W., & Zoratto, F. (2017). The current clinical knowledge on the treatment of gambling disorder: A summary. Synapse. doi:10.1002/syn.21976. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28420033
- Karamanakos, P. N., Pappas, P., Stephanou, P., & Marselos, M. (2001). Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism. Pharmacology and Toxicology, 88(2), 106–110. doi:pto880208 [pii]. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11169169
- Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N. A., Winters, K. C., & Shaffer, H. J. (2008). DSM-IV pathological gambling in the national comorbidity survey replication. Psychol Med, 38(9), 1351–1360. doi:10.1017/S0033291708002900. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18257941
- Kim, S. W., & Grant, J. E. (2001). An open naltrexone treatment study in pathological gambling disorder. International Clinical Psychopharmacology, 16(5), 285–289. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1155277210.1097/00004850-200109000-00006
- Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. Biological Psychiatry, 49(11), 914–921. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1137740910.1016/S0006-3223(01)01079-4
- Kim, S. W., Grant, J. E., Eckert, E. D., Faris, P. L., & Hartman, B. K. (2006). Pathological gambling and mood disorders: Clinical associations and treatment implications. Journal of Affective Disorders, 92(1), 109–116. doi:10.1016/j.jad.2005.12.040. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16443282
- Kovács, I., Richman, M. J., Janka, Z., Maraz, A., & Andó, B. (2017). Decision making measured by the Iowa Gambling Task in alcohol use disorder and gambling disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence, 181, 152–161. doi:10.1016/j.drugalcdep.2017.09.023. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29055269
- Le Foll, B., & Boileau, I. (2013). Repurposing buspirone for drug addiction treatment. The International Journal of Neuropsychopharmacology, 16(2), 251–253. doi:10.1017/S1461145712000995. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23174122
- Lefoll, B., Goldberg, S. R., & Sokoloff, P. (2005). The dopamine D3 receptor and drug dependence: Effects on reward or beyond? Neuropharmacology, 49(4), 525–541. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1596353810.1016/j.neuropharm.2005.04.022
- Li, X., Lu, Z. L., D’Argembeau, A., Ng, M., & Bechara, A. (2010). The Iowa gambling task in fMRI images. Hum Brain Mapp, 31(3), 410–423. doi:10.1002/hbm.20875. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19777556
- Linnet, J., Rojskjaer, S., Nygaard, J., & Maher, B. A. (2006). Episodic chasing in pathological gamblers using the Iowa gambling task. [Research Support, Non-U.S. Gov’t]. Scandinavian Journal of Psychology, 47(1), 43–49. doi:10.1111/j.1467-9450.2006.00491.x. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16433661
- Linnet, J., Møller, A., Peterson, E., Gjedde, A., & Doudet, D. (2011). Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scandinavian Journal of Psychology, 52(1), 28–34. doi:10.1111/j.1467-9450.2010.00837.x. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20704689
- Linnet, J., Mouridsen, K., Peterson, E., Møller, A., Doudet, D. J., & Gjedde, A. (2012). Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry Research: Neuroimaging, 204(1), 55–60. doi:10.1016/j.pscychresns.2012.04.012. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22889563
- Lobo, D. S., Aleksandrova, L., Knight, J., Casey, D. M., el-Guebaly, N., Nobrega, J. N., & Kennedy, J. L. (2015). Addiction-related genes in gambling disorders: New insights from parallel human and pre-clinical models. Molecular Psychiatry, 20(8), 1002–1010. doi:10.1038/mp.2014.113. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25266122
- Lorains, F. K., Cowlishaw, S., & Thomas, S. A. (2011). Prevalence of comorbid disorders in problem and pathological gambling: Systematic review and meta-analysis of population surveys. Addiction, 106(3), 490–498. doi:10.1111/j.1360-0443.2010.03300.x. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21210880
- Marazziti, D., Golia, F., Picchetti, M., Pioli, E., Mannari, P., Lenzi, F., … Conversano, Ciro (2008). Decreased density of the platelet serotonin transporter in pathological gamblers. Neuropsychobiology, 57(1-2), 38–43. doi:10.1159/000129665. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18451636
- Marazziti, D., Baroni, S., Masala, I., Giannaccini, G., Betti, L., Palego, L., & Dell’Osso, Mario Catena (2009). [(3)H]-YM-09151-2 binding sites in human brain postmortem. Neurochemistry International, 55(7), 643–647. doi:10.1016/j.neuint.2009.06.005. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19540292
- Martinez, D., Gil, R., Slifstein, M., Hwang, D. R., Huang, Y., Perez, A., & Kegeles, Lawrence. (2005). Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biological Psychiatry, 58(10), 779–786. doi:10.1016/j.biopsych.2005.04.044. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16018986
- Meyer, G., Schwertfeger, J., Exton, M. S., Janssen, O. E., Knapp, W., Stadler, M. A., & Kruger, T. H. (2004). Neuroendocrine response to casino gambling in problem gamblers. [Clinical Trial Comparative Study Research Support, Non-U.S. Gov’t]. Psychoneuroendocrinology, 29(10), 1272–1280. doi:10.1016/j.psyneuen.2004.03.005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15288706
- Millan, M. J., Dekeyne, A., Rivet, J. M., Dubuffet, T., Lavielle, G., & Brocco, M. (2000). S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. [Comparative Study]. J Pharmacol Exp Ther, 293(3), 1063–1073. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10869411
- Müller, C. A., Banas, R., Heinz, A., & Hein, J. (2011). Treatment of pathological gambling with disulfiram: A report of 2 cases. [Case Reports Letter]. Pharmacopsychiatry, 44(2), 81–83. doi:10.1055/s-0031-1271683. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21328196
- Musacchio, J. M., Goldstein, M., Anagnoste, B., Poch, G., & Kopin, I. J. (1966). Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther, 152(1), 56–61. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5937402
- Mutschler, J., Buhler, M., Grosshans, M., Diehl, A., Mann, K., & Kiefer, F. (2010). Disulfiram, an option for the treatment of pathological gambling? [Case Reports Research Support, Non-U.S. Gov’t]. Alcohol and Alcoholism, 45(2), 214–216. doi:10.1093/alcalc/agp093. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20083479
- Newman, A. H., Blaylock, B. L., Nader, M. A., Bergman, J., Sibley, D. R., & Skolnick, P. (2012). Medication discovery for addiction: Translating the dopamine D3 receptor hypothesis. [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Review]. Biochemical Pharmacology, 84(7), 882–890. doi:10.1016/j.bcp.2012.06.023. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22781742
- Nobrega, J. N., Hedayatmofidi, P. S., & Lobo, D. S. (2016). Strong interactions between learned helplessness and risky decision-making in a rat gambling model. Scientific Reports, 6, 1177. doi:10.1038/srep37304. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27857171
- O’Carroll, R. E., & Papps, B. P. (2003). Decision making in humans: The effect of manipulating the central noradrenergic system. Journal of Neurology, Neurosurgery & Psychiatry, 74(3), 376–378. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1258893310.1136/jnnp.74.3.376
- Pallanti, S., Bernardi, S., Quercioli, L., DeCaria, C., & Hollander, E. (2006). Serotonin dysfunction in pathological gamblers: Increased prolactin response to Oral m-CPP versus placebo. CNS Spectrums, 11(12), 956–965. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1714640910.1017/S1092852900015145
- Pallanti, S., Bernardi, S., Allen, A., Chaplin, W., Watner, D., DeCaria, C. M., & Hollander, E. (2010). Noradrenergic function in pathological gambling: Blunted growth hormone response to clonidine. Journal of Psychopharmacology, 24(6), 847–853. doi:10.1177/0269881108099419 [pii]. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19028836
- Pallesen, S., Molde, H., Arnestad, H. M., Laberg, J. C., Skutle, A., Iversen, E., & Støylen, Inge Jarl. (2007). Outcome of pharmacological treatments of pathological gambling: A review and meta-analysis. [Meta-Analysis Review]. Journal of Clinical Psychopharmacology, 27(4), 357–364. doi:10.1097/jcp.013e3180dcc304d. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17632219
- Petry, N. M., Stinson, F. S., & Grant, B. F. (2005). Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 66(5), 564–574. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1588994110.4088/JCP.v66n0504
- Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., & Schwartz, Jean-Charles. (1999). Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature, 400(6742), 371–375. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1043211610.1038/22560
- Potenza, M. N., Leung, H. C., Blumberg, H. P., Peterson, B. S., Fulbright, R. K., Lacadie, C. M., … Skudlarski, Pawel (2003). An fMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. American Journal of Psychiatry, 160(11), 1990–1994. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1459474610.1176/appi.ajp.160.11.1990
- Potenza, M. N., Steinberg, M. A., Skudlarski, P., Fulbright, R. K., Lacadie, C. M., Wilber, M. K., & Rounsaville, B. E. (2003). Gambling urges in pathological gambling: A functional magnetic resonance imaging study. Archives of General Psychiatry, 60(8), 828–836. doi:10.1001/archpsyc.60.8.828. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12912766
- Pushparaj, A., Kim, A. S., Musiol, M., Zangen, A., Daskalakis, Z. J., Zack, M., & Winstanley, Catharine A (2015). Differential involvement of the agranular vs granular insular cortex in the acquisition and performance of choice behavior in a rodent gambling task. Neuropsychopharmacology, 40(12), 2832–2842. doi:10.1038/npp.2015.133. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25953358
- Reuter, J., Raedler, T., Rose, M., Hand, I., Gläscher, J., & Büchel, C. (2005). Pathological gambling is linked to reduced activation of the mesolimbic reward system. [Comparative Study Research Support, Non-U.S. Gov’t]. Nature Neuroscience, 8(2), 147–148. doi:10.1038/nn1378. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15643429
- Robbins, T. W. (2002). The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. [Research Support, Non-U.S. Gov’t Review]. Psychopharmacology, 163(3-4), 362–380. doi:10.1007/s00213-002-1154-7. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12373437
- Rosenberg, O., Dinur, L. K., & Dannon, P. N. (2013). Four-year follow-up study of pharmacological treatment in pathological gamblers. Clinical Neuropharmacology, 36(2), 42–45. doi:10.1097/WNF.0b013e31828740ea. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23503545
- Roy, A., Adinoff, B., Roehrich, L., Lamparski, D., Custer, R., Lorenz, V., & Linnoila, M. (1988). Pathological gambling. Archives of General Psychiatry, 45(4), 369–373. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/245149010.1001/archpsyc.1988.01800280085011
- Schroeder, J. P., Cooper, D. A., Schank, J. R., Lyle, M. A., Gaval-Cruz, M., Ogbonmwan, Y. E., & Pozdeyev, Nikita. (2010). Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase. [Research Support, N.I.H., Extramural]. Neuropsychopharmacology, 35(12), 2440–2449. doi:10.1038/npp.2010.127. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20736996
- Schroeder, J. P., Alisha Epps, S. A., Grice, T. W., & Weinshenker, D. (2013). The selective dopamine beta-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology, 38(6), 1032–1038. doi:10.1038/npp.2012.267. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23303068
- Sibley, D. R., & Monsma, F. J. (1992). Molecular biology of dopamine receptors. Trends in Pharmacological Sciences, 13, 61–69.10.1016/0165-6147(92)90025-2
- Silveira, M. M., Malcolm, E., Shoaib, M., & Winstanley, C. A. (2015). Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways. Behavioural Brain Research, 281, 86–95. doi:10.1016/j.bbr.2014.12.029. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25529186
- Silveira, M. M., Murch, W. S., Clark, L., & Winstanley, C. A. (2016). Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine’s effect on impulsive action in adulthood. Behavioural Pharmacology, 27(4), 350–363. doi:10.1097/FBP.0000000000000203. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26650252
- Toplak, M. E., Sorge, G. B., Benoit, A., West, R. F., & Stanovich, K. E. (2010). Decision-making and cognitive abilities: A review of associations between Iowa Gambling Task performance, executive functions, and intelligence. Clinical Psychology Review, 30(5), 562–581. doi:10.1016/j.cpr.2010.04.002. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20457481
- Tremblay, M., & Winstanley, C. A. (2016). Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task. Behavioural Brain Research, 314, 143–151. doi:10.1016/j.bbr.2016.08.016. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27515288
- de Visser, L., Homberg, J. R., Mitsogiannis, M., Zeeb, F. D., Rivalan, M., Fitoussi, A., & Dellu-Hagedorn, F. (2011). Rodent versions of the IOWA gambling task: Opportunities and challenges for the understanding of decision-making. Front Neurosci, 5, 109. doi:10.3389/fnins.2011.00109. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22013406
- Volkow, N. D., Fowler, J., Wang, G.-J., Hitzemann, R., Logan, J., Schlyer, David J., & Dewey, Stephen L. (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse, 14, 169–177.10.1002/(ISSN)1098-2396
- Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008). alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol, 42(2), 91–97. doi:S0741-8329(08)00015-3 [pii]10.1016/j.alcohol.2007.12.002. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18358987
- Wang, G. B., Zhang, X. L., Zhao, L. Y., Sun, L. L., Wu, P., Lu, L., & Shi, J. (2012). Drug-related cues exacerbate decision making and increase craving in heroin addicts at different abstinence times. Psychopharmacology, 221(4), 701–708. doi:10.1007/s00213-011-2617-5. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22207241
- Wee, S., Mandyam, C. D., Lekic, D. M., & Koob, G. F. (2008). Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. European Neuropsychopharmacology, 18(4), 303–311. doi:10.1016/j.euroneuro.2007.08.003. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17920248
- Winstanley, C. A., & Clark, L. (2016). Translational models of gambling-related decision-making. Curr Top Behav Neurosci, 28, 93–120. doi:10.1007/7854_2015_5014. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27418069
- Zack, M., & Poulos, C. X. (2007). A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology, 32(8), 1678–1686. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1720301310.1038/sj.npp.1301295
- Zeeb, F. D., & Winstanley, C. A. (2011). Lesions of the Basolateral Amygdala and orbitofrontal cortex differentially affect acquisition and performance of a rodent gambling task. Journal of Neuroscience, 31(6), 2197–2204. doi:10.1523/JNEUROSCI.5597-10.2011. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21307256
- Zeeb, F. D., & Winstanley, C. A. (2013). Functional disconnection of the orbitofrontal cortex and basolateral amygdala impairs acquisition of a rat gambling task and disrupts animals' ability to alter decision-making behavior after reinforcer devaluation. Journal of Neuroscience, 33(15), 6434–6443. doi:10.1523/JNEUROSCI.3971-12.2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23575841
- Zeeb, F. D., Robbins, T. W., & Winstanley, C. A. (2009). Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. [Research Support, Non-U.S. Gov’t]. Neuropsychopharmacology, 34(10), 2329–2343. doi:10.1038/npp.2009.62. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19536111
- Zeeb, F. D., Wong, A. C., & Winstanley, C. A. (2013). Differential effects of environmental enrichment, social-housing, and isolation-rearing on a rat gambling task: Dissociations between impulsive action and risky decision-making. Psychopharmacology, 225(2), 381–395. doi:10.1007/s00213-012-2822-x. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22864967
- Zeeb, F. D., Baarendse, P. J., Vanderschuren, L. J., & Winstanley, C. A. (2015). Inactivation of the prelimbic or infralimbic cortex impairs decision-making in the rat gambling task. Psychopharmacology (Berl),. doi:10.1007/s00213-015-4075-y. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26387517
- Zhang, X. Y., & Kosten, T. A. (2005). Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Biological Psychiatry, 57(10), 1202–1204. doi:10.1016/j.biopsych.2005.02.003. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15866561
- Zhang, X. L., Wang, G. B., Zhao, L. Y., Sun, L. L., Wang, J., Wu, P., & Lu, Lin. (2012). Clonidine improved laboratory-measured decision-making performance in abstinent heroin addicts. PLoS ONE, 7(1), e29084. doi:10.1371/journal.pone.0029084. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22291886